CARCINOMA, HEPATOCELLULAR
Clinical trials for CARCINOMA, HEPATOCELLULAR explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, HEPATOCELLULAR trials appear
Sign up with your email to follow new studies for CARCINOMA, HEPATOCELLULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo vs standard therapy: which works better for liver cancer?
Disease control TerminatedThis study aimed to compare two treatment approaches for intermediate-stage liver cancer that can't be cured surgically. It tested whether a combination of two cancer drugs (regorafenib and pembrolizumab) works better than standard liver-directed treatments (TACE or TARE). The tr…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE3 • Sponsor: Translational Research in Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Tiny trial tests custom radiation doses for tough liver tumors
Disease control TerminatedThis study tested a personalized radiation treatment for adults with liver cancer that could not be removed by surgery. Doctors first gave a tiny 'scout' dose to see where it went, then calculated a custom therapeutic dose for each patient. The main goals were to check the treatm…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Scientists track immune cells during radiation to boost future cancer treatments
Knowledge-focused TerminatedThis study aimed to understand how high-dose radiation therapy affects the body's immune system in patients with liver, colorectal, skin, or kidney cancers. Researchers collected blood samples from 28 patients before, during, and after radiation treatment to measure immune cell c…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC